CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-03 | RYAN ARTHUR F Director | Sale | −1 | $726.03 | $726 | 19,558 |
| 2022-10-03 | RYAN ARTHUR F Director | Sale | −18 | $727.52 | $13K | 19,540 |
| 2022-10-03 | RYAN ARTHUR F Director | Sale | −19 | $728.23 | $14K | 19,521 |
| 2022-10-03 | RYAN ARTHUR F Director | Sale | −2 | $730.00 | $1K | 19,519 |
| 2022-10-03 | RYAN ARTHUR F Director | Sale | −6 | $731.49 | $4K | 19,513 |
| 2022-10-03 | RYAN ARTHUR F Director | Sale | −7 | $732.47 | $5K | 19,506 |
| 2022-10-03 | RYAN ARTHUR F Director | Sale | −24 | $733.64 | $18K | 19,482 |
| 2022-10-03 | Thompson Craig B. Director | Grant or award | +279 | 279 | ||
| 2022-10-03 | Thompson Craig B. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,216 | 3,216 | ||
| 2022-10-03 | Tessier-Lavigne Marc Director | Option exercise | +3,612 | $413.33 | $1.5M | 5,881 |
| 2022-10-03 | Tessier-Lavigne Marc Director | Sale | −3,612 | $718.00 | $2.6M | 2,269 |
| 2022-10-03 | Tessier-Lavigne Marc Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,612 | 0 | ||
| 2022-09-30 | Tessier-Lavigne Marc Director | Option exercise | +3,428 | $413.33 | $1.4M | 5,697 |
| 2022-09-30 | Tessier-Lavigne Marc Director | Sale | −3,428 | $698.00 | $2.4M | 2,269 |
| 2022-09-30 | Tessier-Lavigne Marc Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,428 | 3,612 | ||
| 2022-09-29 | Tessier-Lavigne Marc Director | Option exercise | +3,798 | $413.33 | $1.6M | 6,067 |
| 2022-09-29 | Tessier-Lavigne Marc Director | Sale | −16 | $686.89 | $11K | 6,051 |
| 2022-09-29 | Tessier-Lavigne Marc Director | Sale | −321 | $687.90 | $221K | 5,730 |
| 2022-09-29 | Tessier-Lavigne Marc Director | Sale | −637 | $688.71 | $439K | 5,093 |
| 2022-09-29 | Tessier-Lavigne Marc Director | Sale | −1,009 | $689.56 | $696K | 4,084 |
Page 71 of 105 · 2,088 trades